RPID · NASDAQ · Medical - Devices

Rapid Micro Biosystems (RPID)

Automates microbial quality-control workflows for pharmaceutical, medical-device, and personal-care manufacturing.

$1.19
After hours+0.03 (+3.03%)
At close$1.16(+2.21%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue6667887781188
Cost of revenue8777777561287
Gross profit−20−2011022001
131213131311121414121414
Research & development334443434333
109999889991110
Selling & marketing333433333333
General & administrative666665666577
Other expenses000000022000
Operating income−14−12−14−13−12−10−12−12−11−12−14−12
11111100000−1
Interest income111111000000
Interest expense000000000111
Other non-operating income0−1−1−1−1−1000−100
Income before tax−13−11−13−13−11−10−11−12−11−12−14−13
Income tax expense000000000000
Net income from continuing operations−13−11−13−13−11−10−11−12−12−12−14−13
Net income−13−11−13−13−11−10−11−12−12−12−14−13
EPS, basic−$0.31−$0.26−$0.31−$0.29−$0.26−$0.22−$0.26−$0.27−$0.25−$0.28−$0.31−$0.27
EPS, diluted−$0.31−$0.26−$0.31−$0.29−$0.26−$0.22−$0.26−$0.27−$0.25−$0.28−$0.31−$0.27
Weighted average shares, basic434343444444444545454547
Weighted average shares, diluted434343444444444545454547
EBITDA−14−10−13−12−11−9−10−11−10−11−13−12
Depreciation & amortization111111111110
EBIT−14−11−13−13−11−10−11−12−11−12−14−12